KRAS and lung cancer: Davidson et al. showed that in lung cancer models of KrasG12D and Tp53 (KP mice), KrasG12D promotes increased glucose metabolism to generate pyruvate and lactate, consistent with observations that Kras oncogenic mutations yield elevated lactate (Davidson et al., 2016).